To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cannabis Testing Market size was valued at USD 7 Billion in 2022 and is poised to grow from USD 7.9 Billion in 2023 to USD 21.9 Billion by 2031, growing at a CAGR of 13.5% in the forecast period (2024-2031).

The Cannabis Testing Market thrives within a dynamic and competitive landscape, marked by a blend of established brands, emerging players, and specialized producers. Innovation stands as a pivotal competitive factor within this arena. Foremost brands heavily invest in research and development, continuously introducing novel flavors, diverse packaging formats, and health-centric variations to address evolving consumer tastes. Often, these industry leaders set the trends within the market, leveraging their innovative strides to not only meet but also shape the shifting preferences of consumers. This emphasis on pioneering developments underscores the competitive edge and adaptability crucial for success in this ever-evolving sector. 'Shimadzu Scientific Instruments', 'Agilent Technologies Inc.', 'Danaher Corporation', 'Accelerated Technology Laboratories Inc.', 'Merck KGaA (Sigma Aldrich)', 'Pharmlabs LLC', 'Restek Corporation', 'Sartorius AG', 'Steep Hill Halent Laboratories Inc.', 'PerkinElmer Inc.', 'Digipath Inc.', 'AB Sciex Pte. Ltd'

Medical cannabis has risen as a promising therapeutic avenue for a spectrum of medical conditions, showcasing its effectiveness in alleviating symptoms and enhancing the quality of life for patients. Its notable impact includes mitigating chemotherapy-induced nausea, stimulating appetite among individuals combating AIDS, and managing muscular spasms in those diagnosed with multiple sclerosis, supported by extensive documentation.

The driving force behind this growth stems from robust government backing for the legalization of medical marijuana in these regions. This supportive stance toward medical cannabis legalization has become a magnet for investors, major industry players, and governmental bodies, all eyeing opportunities to invest in bolstering cannabis testing infrastructure.

In 2022, North America emerged as the powerhouse of the cannabis testing market, commanding an impressive 84.6% revenue share and poised for sustained growth with a significant CAGR projected for the forecast period. A key driving force behind this expansion is the proliferation of testing laboratories, a direct response to stringent governmental regulations governing marijuana cultivation practices in the region.

Feedback From Our Clients

Global Cannabis Testing Market

Product ID: SQMIG30C2143

$5,300
BUY NOW